Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Atezolizumab - a fully humanized IgG1 mAb blocking interaction of PD-L1 with both PD-1 and B7.1, but not interaction of PD-L2 with [PD-1]
PD-L1 is a protein that hinders the immune system from attacking cancer cells. By doing so, it aims to reactivate the immune response to fight the cancer and inhibit its growth
Atezolizumab is approved for the treatment of non-small cell lung cancer (NSCLC) and advanced liver cancer (hepatocellul…